Methylphenidate Tied to Brain Changes in Boys With ADHD
Treatment with methylphenidate affects specific tracts in brain white matter in boys with attention-deficit/hyperactivity disorder.
Attention-Deficit/Hyperactivity Disorder
ADHD Treatment Adhansia XR Now Available
Adhansia XR (methylphenidate HCl extended-release capsules) for the treatment of attention deficit hyperactivity disorder in patients aged 6 years and older, has launched.
Methylphenidate Beneficial in ADHD After 2 or More Years
Current guidelines include recommendations on how to prescribe methylphenidate, but lack of recommendations regarding the long-term use of the drug.
Adhansia XR Soon to Be Available for ADHD
Adhansia XR (methylphenidate HCl extended-release capsules) is expected to be available as of July 15, 2019 for the treatment of attention deficit hyperactivity disorder (ADHD) in patients 6 years of age and older, according to Adlon Therapeutics.
Medicaid, Depression, ADHD Raise Risks for Hospitalization in Pediatric Atopic Dermatitis
Researchers sought to determine risk factors for hospitalization in children with atopic dermatitis.
Cortical Surface Area, Thickness Differentiate Children With ADHD From Controls
Subtle differences in cortical surface area are widespread in children with attention-deficit/hyperactivity disorder, confirming involvement of the frontal cortex.
Pre-Existing Mental Health Vulnerabilities Associated With Being Bullied
Prevention programs may improve long-term outcomes in children and adolescents by addressing pre-existing vulnerabilities that increase the risk for exposure to bullying.
Can Maternal Diet Affect the Risk of ADHD Development in Offspring?
A higher omega-6 to omega-3 ratio in the mother’s diet may increase the risk of attention deficit hyperactivity disorder (ADHD) symptoms in offspring, according to findings from a study published in the Journal of Pediatrics. Researchers quantified the levels of omega-6 and -3 that reached the fetus by sampling umbilical cord plasma. Omega-3 and omega-6…
Risk of New-Onset Psychosis Examined Among ADHD Patients Treated With Stimulants
A recent study published in the New England Journal of Medicine assessed the risk of new-onset psychosis among adolescents and young adults with attention deficit hyperactivity disorder (ADHD) initiated on various stimulant medications.
Prenatal Valproate Exposure Associated With Increased Risk for ADHD
Researchers sought to determine whether prenatal exposure to valproate and other antiepileptic drugs (AEDs) increases the risk for ADHD in offspring.
